3D Medicines Bleeds Red Ink As It Struggles to Swim in ‘Red Ocean’
The loss-making innovative oncology drug company with just one approved product on the market is making a third tilt for a listing on the Hong Kong Stock Exchange Key Takeaways:…
A.US
Recent Articles
RELATED ARTICLES
-
Profit setback for Simcere Pharma in novel drugs quest
2096.HK
-
FAST NEWS: Alibaba Pictures bleeds red ink on pandemic movie blow
1060.HK
-
BeiGene still bleeding red ink despite blockbuster drug
BGNE.US 6160.HK 688235.SHG
-
With no cure in sight, drugs firm LianBio begins exit strategy
LIAN.US
-
Unpaid debts, fleeing directors leave Sino-Ocean Group in dire straits
3377.HK
-
Everest reaches new heights on growing drug sales
1952.HK
-
Henlius finds elixir in first profits, scraps A-share IPO
2696.HK
Discover hidden China stock gems in our weekly newsletter